- FoI Number
- 2024-195
- Subject
- Immunoglobulin Treatment
- Date Received
- 02/07/2024
- Request and Response
-
- In the past 3 months, how many patients have received the following treatments (for any disease):
Berinert (Human C1-esterase inhibitor)
0
Cinryze (Human C1-esterase inhibitor)
0
Firazyr (Icatibant)
0
Icatibant - any brand except Firazyr
0
Orladeyo (Berotralstat)
0
Ruconest (Recombinant human C1-esterase inhibitor)
0
Takhzyro (Lanadelumab)
0
- In the past 3 months, how many patients have received the following immunoglobulin treatments (for any disease):
Cutaquig
0
Cuvitru
0
Gammagard
0
Gammanorm
0
Hizentra
0
Hyqvia
0
Intratect
0
Iqymune
0
Kiovig
<5
Privigen
<5
Octagam
0
Panzyga
0
Subgam
0
Any other normal immunoglobulin
0
Where we have given <5 answers this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
